Moderna vaccine antibodies last at least 6 months; lung transplant can save some COVID-19 survivors - Yahoo! Voices

  A follow-up study of 33 people who received Moderna Inc's COVID-19 vaccine in early trials show the antibodies it induced are still present six months after the second dose.

  Surgeons worldwide have been performing lung transplants in COVID-19 survivors with irreversible lung damage, and an international group of transplant experts has proposed guidelines for selection of eligible patients.

They said transplants should be performed at least four weeks after a diagnosis of irreversible lung damage.

In the United States alone, more than 50 double lung transplants have been performed on COVID-19 survivors, and all the patients are alive, said Dr.

A study published in The Lancet Respiratory Medicine that examined 12 of the first double-lung transplants performed in COVID-19 patients in the United States, Italy, Austria and India showed that all but two survived and are doing well, said co-author Bharat.

  The mRNA COVID-19 vaccine from Pfizer and BioNTech is safe for patients being treated with cancer immunotherapies like Merck & Co's Keytruda and Opdivo sold by Bristol Myers Squibb, Israeli physicians said in a report published in The Lancet Oncology.

"We looked at our patients only a few weeks from the second dose and cannot rule out the possibility of long-term side effects," Wolf said.

Fewer than half of patients who experienced a delayed skin reaction after the first dose experienced a recurrence with the second dose.

A follow-up study of 33 people who received Moderna Inc's COVID-19 vaccine in early trials show the antibodies it induced are still present six months after the second dose

The researchers conducting the Moderna vaccine study will continue to follow the same volunteers to see whether the antibodies last longer than six months